FIELD: medicine.
SUBSTANCE: invention relates to medicine and concerns a method for treating patients with chronic kidney disease of stage V at the dialysis stage, consisting in program hemodialysis and drug exposure, including taking drugs belonging to the groups of angiotensin converting enzyme inhibitors and/or angiotensin receptor blockers, statins, antiplatelet agents, drugs that affect calcium-phosphorus metabolism, ketoanalogues of essential amino acids, where a high-protein dietary component medicinal effects include an immobilized liquid probiotic “LB-complex-L” with two 50-day courses with an interval between them of 4 months at the rate of 10 ml once a day.
EFFECT: invention provides the restoration of the evolutionarily determined structure of the microbiocenosis and the normalization of its function.
1 cl, 8 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATMENT OF PATIENTS WITH CHRONIC KIDNEY DISEASE C3-C5 AT DIALYSIS STAGE, EXCLUDING PYELONEPHRITIS, UROLITHIASIS | 2017 |
|
RU2646467C1 |
METHOD FOR PREVENTING INFECTIOUS COMPLICATIONS ASSOCIATED WITH THE PERITONEAL CATHETER INSTALLATION IN THE PATIENTS WITH CHRONIC C5 RENAL DISEASE ON PERITONEAL DIALYSIS | 2018 |
|
RU2690951C1 |
METHOD OF TREATING PATIENTS WITH HEPATIC CIRRHOSIS | 2012 |
|
RU2509566C1 |
METHOD FOR PREDICTION OF RISK OF PERMANENT VASCULAR ACCESS THROMBOSIS WITHIN 6 MONTHS TO 1 YEAR IN PATIENTS ON PROGRAM HAEMODIALYSIS | 2020 |
|
RU2736206C1 |
SCREENING DIAGNOSTIC TECHNIQUE FOR ARTERIOVENOUS FISTULA STENOSIS IN PATIENTS WITH END-STAGE CHRONIC RENAL DISEASE | 2012 |
|
RU2508544C1 |
METHOD OF PREDICTING EFFICIENCY OF PLANNED STANDARD THERAPY OF ACUTE NEPHRITIS | 2010 |
|
RU2421126C1 |
DIAGNOSTIC TECHNIQUE FOR ARTERIOVENOUS FISTULA STENOSIS IN LONG-TERM HEMODIALYSIS PATIENTS WITH END-STAGE CHRONIC RENAL DISEASE | 2013 |
|
RU2522397C1 |
METHOD FOR THE TREATMENT OF UNCOMPLICATED NECROTIZING ENTEROCOLITIS IN NEWBORNS WITH A BACTERIAL INFECTION AND IF INTRAUTERINE INFECTION IS SUSPECTED | 2021 |
|
RU2771856C1 |
METHOD OF PERSONALIZED TREATMENT OF CHRONIC RENAL DISEASE IN PATIENTS WITH DIABETIC NEPHROPATHY | 2018 |
|
RU2687256C1 |
METHOD FOR CORRECTION OF COMPOSITION OF INTESTINAL MICROFLORA IN CHILDREN | 2022 |
|
RU2801611C1 |
Authors
Dates
2021-08-11—Published
2020-11-24—Filed